In The News

NJ.com, November 2022
In her regular column, Dr. Papka answers reader questions about new drug treatments and clinical trials to treat and prevent Alzheimer's disease.

NJ.com, November 2022
In her regular column, Dr. Papka answers reader questions about untested neutraceutical treatments for memory, and the symptoms of Alzheimer's

The Elixir Factor, September 2022
On this episode of The Elixir Factor, Jim and Geri Taylor share their story of fighting Alzheimer's with courage and resilience, and finding ways to appreciate life together despite a chronic diagnosis.

NYTimes.com, April 2021
They Have Alzheimer’s. This Clinical Trial May Be a Last Hope.

NJ.com, March 2021
This Alzheimer’s drug made from seaweed got approved in China. Now it’s being tested in N.J.

Lilly.com, January 2021
Lilly's Donanemab Slows Clinical Decline of Alzheimer's Disease in Positive Phase 2 Trial

Cortexyme.com, January 2021
Cortexyme Announces Pipeline Update and Anticipated 2021 Milestones

NJ.com, February 2019
Scientists get a ‘total surprise’ and a promising new clue for how to cure Alzheimer’s

NJ.com/Star Ledger, September 2017
Is it Alzheimer’s? Turn your worries into answers and help

Edge, September 2015
Fear Factor
The stigma attached to Alzheimer’s — and a dearth of clinical trial volunteers — may be slowing the development of a breakthrough drug.

Daily RX, April 19, 2015
Strategies That May Keep Your Brain Sharp
Cognitive aging may be slowed with several health strategies

The Daily Record, January 21, 2015
Part One: Morris therapists go mobile as seniors age in place

See Dr. Papka’s Interview on 30 Medical Minutes, November 2014